Since adenosine receptor A2B (A2BAR) plays an essential role in the pathogenesis of chronic inflammatory airway diseases such as asthma, COPD, and pulmonary fibrosis [12,13,14,15], we investigated a possible effect of EA 575® on this receptor. Here, ADORA2B is linked to pulmonary fibrosis.